Skip to Main Content

Paper Details

Reversing anticoagulant effects of novel oral anticoagulants: role of ciraparantag, andexanet alfa, and idarucizumab.
Vasc Health Risk Manag
64
2016
Author NameAffiliation
Tiffany Y HuMayo Medical School
Samuel J AsirvathamMayo Clinic
  • 1 - 2

Datasets

Release 1.2